pubmed.ncbi.nlm.nih.gov

Lamotrigine and pregnancy - PubMed

Case Reports

Lamotrigine and pregnancy

A Quattrini et al. Ital J Neurol Sci. 1996 Dec.

No abstract available

Pregnancy Outcomes Following In Utero Exposure to Lamotrigine: A Systematic Review and Meta-Analysis.
Pariente G, Leibson T, Shulman T, Adams-Webber T, Barzilay E, Nulman I. Pariente G, et al. CNS Drugs. 2017 Jun;31(6):439-450. doi: 10.1007/s40263-017-0433-0. CNS Drugs. 2017. PMID: 28434134 Review.
Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.
Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Sabers A, Perucca E, Vajda F; EURAP study group. Tomson T, et al. Lancet Neurol. 2011 Jul;10(7):609-17. doi: 10.1016/S1474-4422(11)70107-7. Epub 2011 Jun 5. Lancet Neurol. 2011. PMID: 21652013
[Stevens-Johnson syndrome after lamotrigine treatment].
Campistol J, Geli M, Llistosella E, Molins J, Llobet M. Campistol J, et al. Rev Neurol. 1995 Nov-Dec;23(124):1236-8. Rev Neurol. 1995. PMID: 8556627 Spanish.
Lamotrigine versus carbamazepine in epilepsy.
O'Donoghue MF, Sander JW. O'Donoghue MF, et al. Lancet. 1995 May 20;345(8960):1300; author reply 1300-1. Lancet. 1995. PMID: 7605482 No abstract available.
Lamotrigine in pregnancy: safety profile and the risk of malformations.
Prakash, Prabhu LV, Nasar MA, Rai R, Madhyastha S, Singh G. Prakash, et al. Singapore Med J. 2007 Oct;48(10):880-3. Singapore Med J. 2007. PMID: 17909669 Review.

Ameliorative effects of supplemental folinic acid on Lamotrigine-induced fetal malformations in the mouse.
Abdulrazzaq YM, Shafiullah M, Kochyil J, Padmanabhan R, Bastaki SMA. Abdulrazzaq YM, et al. Mol Cell Biochem. 2018 Sep;446(1-2):185-197. doi: 10.1007/s11010-018-3285-0. Epub 2018 Jan 23. Mol Cell Biochem. 2018. PMID: 29363057